As of March 2021 Hikma Pharmaceuticals has a market cap of $6.89 B. This makes Hikma Pharmaceuticals the world's 1886th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2021 | $7.47 B | -2.56% |
2020 | $7.66 B | 13.88% |
2019 | $6.73 B | 22.87% |
2018 | $5.48 B | 49.6% |
2017 | $3.66 B | -41.8% |
2016 | $6.29 B | -15.35% |
2015 | $7.43 B | 23.71% |
2014 | $6.01 B | 77.47% |
2013 | $3.38 B | 55.02% |
2012 | $2.18 B | 26.88% |
2011 | $1.72 B | -18.98% |
2010 | $2.12 B | 58.77% |
2009 | $1.33 B | 71.94% |
2008 | $0.77 B | -38.57% |
2007 | $1.26 B | 20.15% |
2006 | $1.05 B |